Return to Trial Database

BTCRC-HEM15-027

Phase I/II Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma: BTCRC-HEM15-027

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial BTCRC-HEM15-027 being conducted in.

Masonic Cancer Center, University of Minnesota

University of Iowa Holden Comprehensive Cancer Center

University of Wisconsin Carbone Cancer Center